Latest Sigrid Therapeutics News & Updates
See the latest news and media coverage for Sigrid Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.
Pioneer of non-pharmaceutical metabolic health solutions
sigridthx.com- Headquarters
- Stockholm, Sweden
- Founded year
- 2014
- Company type
- Private company
- Number of employees
- 20–50
Latest news about Sigrid Therapeutics
Company announcements
-
Sigrid Therapeutics announces new CEO Claus Kjaersgaard
He focuses on structured commercial scaling rooted in SiPore® technology. 2026 priorities include HCP expansion, regulatory clarity, partnerships, and evidence development.
-
Sigrid Therapeutics appoints Claus Kjaersgaard as CEO
He assumes the role on 1 February 2026, bringing over 15 years of experience in marketing, sales, and business development in FMCG, pharmaceuticals, and healthcare.
-
Sigrid Therapeutics thanks Almi Invest for partnership
The collaboration provided trust, long-term support through research, clinical work, and company growth. CEO Sana Alajmovic reflects on this journey gratefully.
-
Sigrid Therapeutics enters exclusive global licensing and research collaboration
The deal commercializes SiPore® in consumer oral health. It was announced on Jan 21.
Media coverage
-
He takes over the helm at Sigrid Therapeutics
Claus Kjaersgaard becomes new CEO at Sigrid Therapeutics after the company's co-founder Sana Alajmovic has left the position for a corresponding role at Enxymatica, which Medtech Magazine...
-
Sigrid Enters Exclusive Global Licensing and Research Collaboration to Commercialize SiPore® in Consumer Oral Health
STOCKHOLM, Jan. 21, 2026 /PRNewswire/ -- Sigrid Therapeutics (Sigrid) is a Swedish, science-driven consumer health company with a primary focus on metabolic health. Following the...
-
SIGRID Expands into the U.S. Physician Channel Following Successful Pilot Program
STOCKHOLM, Nov. 3, 2025 /PRNewswire/ -- SIGRID, the Swedish innovative consumer care company behind the groundbreaking Glucose Stabiliser powered by patented SiPore® technology, today announced...
-
Diabetes company raises 72 million - her powder will solve diseases
Sigrid Therapeutics wants to combat type 2 diabetes with a powder that is mixed with water. Now the company is raising 72 million to conduct a larger study...
Track Sigrid Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Sigrid Therapeutics competitors & trending companies
Browse news for competitors to Sigrid Therapeutics and other trending companies.
Abarceo Pharma
Fractyl Health
Viking Therapeutics
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy